Summary
Fasting (24 h) normal dogs and depancreatized dogs were injected intravenously with highly purified porcine insulin (Actrapid) in the doses of 0.2 U/kg and 0.5 U/kg, respectively. Blood glucose decreased from 152±41 (SEM) mg/100 ml to 39±7 mg/100 ml in the depancreatized dog and from 95±3 mg/100 ml to 42±4 mg/100 ml in the normal animal. Using a specific antiserum for “pancreatic” glucagon, the circulating level of glucagon immunoreactivity did not rise from the basal value of 247±31 pg/ml in the depancreatized group whereas it rose significantly from 223±24 pg/ml to 321±41 pg/ml in the normal group. In contrast intravenous infusion of 7 g of arginine increased “pancreatic” glucagon immunoreactivity in both groups. Thus, extrapancreatic glucagon of the pancreatic type does not respond to hypoglycaemia but to arginine infusion.
Similar content being viewed by others
References
Matsuyama, T., Foà, P. P.: Plasma glucose, insulin, pancreatic and enteroglucagon levels in normal and depancreatized dogs. Proc. Soc. Exp. Biol. Med.147, 97–102 (1974)
Vranic, M., Pek, S., Kawamori, R.: Increased “glucagon immunoreactivity” in plasma of totally depancreatized dogs. Diabetes23, 905–912 (1974)
Sasaki, H., Rubalcava, B., Baetens, D., Blazquez, E., Srikant, C. B., Orci, L., Unger, R. H.: Identification of glucagon in the gastrointestinal tract. J. Clin. Invest.56, 135–145 (1975)
Blazquez, E., Muñoz-Barragan, L., Patton, G. S., Orci, L., Dobbs, R. E., Unger, R. H.: Gastric A-cell function in insulin-deprived depancreatized dogs. Endocrinology99, 1182–1188 (1976)
Mashiter, K., Harding, P. E., Chou, M., Mashiter, G. D., Stout, J., Diamond, D., Field, J. B.: Persistent pancreatic glucagon but not insulin response to arginine in pancreatectomized dogs. Endocrinology96, 678–693 (1975)
Foà, P. P., Matsuyama, T., Foà, N.: Radioimmunoassay of glucagon. In: Handbook of radioimmunoassay. Abraham, G. E. (Ed.), pp 299–317. New York: Marcel Dekker 1977
Shima, K., Tanaka, R., Morishita, S., Tarai, S., Kumahara, Y., Nishikawa, M.: Studies on the etiology of “brittle diabetes”. Relationship between diabetic instability and insulinogenic reserve. Diabetes26, 717–725 (1977)
Shima, K., Sawazaki, N., Tanaka, R., Tarui, S., Nishikawa, M.: Effect of an exposure to chloramine-T on the immunoreactivity of glucagon. Endocrinology96, 1254–1260 (1975)
Gerich, J. E., Schneider, V., Dippe, S. E., Langlois, M., Noacco, C., Karam, J. H., Forsham, P. H.: Characterization of the glucagon response to hypoglycemia in man. J. Clin. Endocrinol. Metab.38, 77–82 (1974)
Silverman, H., Dunbar, J. C.: The submaxillary gland as a possible source of glucagon. Bull. Sinai Hosp. Detroit22, 192–193 (1974)
Lawrence, A. M., Tan, S., Hojvat, S., Kirsteins, L.: Salivary gland hyperglycemic factor: An extrapancreatic source of glucagon-like material. Science195, 70–72 (1977)
Bathena, S. J., Smith, S. S., Voyles, N. R., Penhos, J. C., Recant, L.: Studies on submaxillary gland immunoreactive glucagon. Biochem. Biophys. Res. Commun.74, 1574–1581 (1977)
LeFebvre, P. J., Luyckx, A. S.: Plasma glucagon after kidney exclusion: Experiments in somatostatin-infused and in eviscerated dogs. Metabolism25, 761–768 (1976)
Muñoz-Barragan, L., Blazquez, E., Patton, S., Dobbs, R. E., Unger, R. H.: Gastric A-cell function in normal dogs. Am. J. Physiol.231, 1057–1068 (1976)
Lefebvre, P. J., Luyckx, A. S.: Factors controlling glucagon release by the isolated perfused dog stomach. Diabetologia13, 413 (1977)
Gerich, J. E., Langlois, M., Noacco, C., Karam, J. H., Forsham, P. H.: Lack of glucagon response to hypoglycemia in diabetes: Evidence for an intrinsic pancreatic alpha cell defect. Science182, 171–173 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuyama, T., Tanaka, R., Shima, K. et al. Lack of gastrointestinal glucagon response to hypoglycaemia in depancreatized dogs. Diabetologia 15, 471–474 (1978). https://doi.org/10.1007/BF02342872
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02342872